Abstract
CYP102A1 is an efficient medium- to long-chain fatty acid hydroxylase that is able to accept a wide range of non-natural substrates which bear no resemblance to the natural ones. 4-Hexylbenzoic acid (HBA) and 4-nonyloxybenzoic acid (NOBA) were identified as CYP102A1 substrates via screening studies using the BD Oxygen Biosensor System. Spectroscopic binding studies showed that these two substrates bind in the active site of CYP102A1 with K d values of 2.6 ± 0.1 μM for HBA and 1.9 ± 0.2 μM for NOBA. NADPH consumption rates in the presence of HBA and NOBA were 45 ± 1 min−1 and 61 ± 1 min−1, respectively. The coupling efficiency for NADPH was 57% for NOBA, while it was 77% for HBA. During whole-cell biotransformations, HBA was converted into ω−1- and ω−2-hydroxyhexylbenzoic acid, whereas NOBA was oxidized to ω−2-hydroxynonyloxybenzoic acid and ω−2,ω−4-dihydroxynonyloxybenzoic acid. HBA was used as a fatty acid mimic to compare whole-cell biotransformations with cell-free extracts. Whole-cell biotransformations carried out in a biphasic system resulted in 86% conversion of 5 mM HBA, producing 3.8 mM ω−2- and 0.5 mM ω−1-hydroxyhexylbenzoic acid in 4 h with a turnover number of 4.1 min−1, whereas 100% conversion of 5 mM HBA was obtained in 1 h with crude cell extracts and a cofactor regeneration system, giving a turnover number of 10.5 min−1.
Similar content being viewed by others
References
Barrow SE, Taylor GW (1987) Gas chromatography and mass spectrometry of eicosanoids. In: Benedetto C, McDonald-Gibson RG, Nigam S, Slater TF (eds) Prostaglandins and related compounds: a practical approach series. IRL, Oxford, pp 99–141
Boddupalli SS, Estabrook RW, Peterson JA (1990) Fatty acid monooxygenation by cytochrome P-450BM-3. J Biol Chem 265:4233–4239
Boddupalli SS, Pramanik BC, Slaughter CA, Estabrook RW, Peterson JA (1992) Fatty acid monooxygenation by P450BM-3: product identification and proposed mechanism for sequential hydroxylation. Arch Biochem Biophys 292:20–28
Budde M, Morr M, Schmid RD, Urlacher VB (2006) Selective hydroxylation of highly branched fatty acids and their derivatives by CYP102A1 from Bacillus megaterium. Chembiochem 7:789–794
Choi S-J, Kim M, Kim SI, Jeon J-K (2003) Microplate assay measurement of cytochrome P450–carbon monoxide complexes. J Biochem Mol Biol 36:332–335
Cryle MJ, Matovic NJ, De Voss JJ (2007) The stereochemistry of fatty acid hydroxylation by cytochrome P450BM3. Tetrahedron Lett 48:133–136
Eiben S (2007) CYP102A P450 monooxygenases: comparative analysis and construction of cytochrome P450 chimeras. Thesis, University of Stuttgart
Eiben S, Kaysser L, Maurer S, Kühnel K, Urlacher VB, Schmid RD (2006) Preparative use of isolated CYP102 monooxygenases—a critical appraisal. J Biotechnol 124:662–669
Fujii T, Narikawa T, Sumisa F, Arisawa A, Takeda K, Kato J (2006) Production of α, ω-alkanediols using Escherichia coli expressing a cytochrome P450 from Acinetobacter sp. OC4. Biosci Biotechnol Biochem 70:1379–1385
Graham-Lorence S, Truan G, Peterson JA, Falck JR, Wei S, Helvig C, Capdevila JH (1997) An active site substitution, F87V, converts cytochrome P450 BM-3 into a regio- and stereoselective (14S, 15R)-arachidonic acid epoxygenase. J Biol Chem 272:1127–1135
Girvan HM, Marshall KR, Lawson RJ, Leys D, Joyce MG, Clarkson J, Smith WE, Cheesman MR, Munro AW (2004) Flavocytochrome P450 BM3 mutant A264E undergoes substrate-dependent formation of a novel heme iron ligand set. J Biol Chem 279:23274–23286
Huang W-C, Westlake ACG, Maréchal J-D, Joyce MG, Moody PCE, Roberts GCK (2007) Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency. J Mol Biol 373:633–651
Li Q-S, Ogawa J, Schmid RD, Shimizu S (2001) Residue size at position 87 of cytochrome P450 BM-3 determines its stereoselectivity in propylbenzene and 3-chlorostyrene oxidation. FEBS Lett 508:249–252
Maurer SC, Kühnel K, Kaysser LA, Eiben S, Schmid RD, Urlacher VB (2005) Catalytic hydroxylation in biphasic systems using CYP102A1 mutants. Adv Synth Catal 347:1090–1098
Modi S, Primrose WU, Boyle JMB, Gibson CF, Lian L-Y, Roberts GCK (1995) NMR studies of substrate binding to cytochrome P450 BM3: comparisons to cytochrome P450cam. Biochemistry 34:8982–8988
Mouri T, Michizoe J, Ichinose H, Kamiya N, Goto M (2006) A recombinant Escherichia coli whole cell biocatalyst harbouring a cytochrome P450cam monooxygenase system coupled with enzymatic cofactor regeneration. Appl Microbiol Biotechnol 72:514–520
Narhi LO, Fulco AJ (1982) Phenobarbital induction of a soluble cytochrome P-450-dependent fatty-acid mono-oxygenase in Bacillus megaterium. J Biol Chem 257:2147–2150
Noble MA, Miles CS, Chapman SK, Lysek DA, Mackay AC, Reid GA, Hanzlik RP, Munro AW (1999) Roles of key active-site residues in flavocytochrome P450BM3. Biochem J 339:371–379
Olry A, Schneider-Belhaddad F, Heintz D, Werck-Reichhart D (2007) A medium-throughput screening assay to determine catalytic activities of oxygen-consuming enzymes: a new tool for functional characterization of cytochrome P450 and other oxygenases. Plant J 51:331–340
Omura T, Sato R (1964) Carbon monoxide-binding pigment of liver microsomes. J Biol Chem 239:2370–2378
Ost TW, Miles CS, Murdoch J, Cheung Y, Reid GA, Chapman SK, Munro AW (2000) Rational re-design of the substrate binding site of flavocytochrome P450 BM3. FEBS Lett 486:173–177
Pflug S, Richter SM, Urlacher VB (2007) Development of a fed-batch process for the production of the cytochrome P450 monooxygenase CYP102A1 from Bacillus megaterium in E. coli. J Biotechnol 129:481–488
Ravichandran KG, Boddupalli SS, Hasermann CA, Peterson JA, Deisenhofer J (1993) Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450’s. Science 261:731–736
Rolo AP, Palmeira MC, Cortopassi AG (2009) Biosensor plates detect mitochondrial physiological regulators and mutations in vivo. Anal Biochem 385:176–178
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, New York
Schneider S, Wubbolts MG, Sanglard D, Witholt B (1998) Biocatalyst engineering by assembly of fatty acid transport and oxidation activities for in vivo application of cytochrome P-450BM-3 Monooxygenase. Appl Environ Microbiol 64:3784–3790
Schneider S, Wubbolts MG, Oesterhelt G, Sanglard D, Witholt B (1999) Controlled regioselectivity of fatty acid oxidation by whole cells producing cytochrome P450BM-3 monooxygenase under varied dissolved oxygen concentrations. Biotechnol Bioeng 64:333–341
Smit MS, Mokgoro MM, Setati E, Nicaud JM (2005) α, ω-Dicarboxylic acid accumulation by acyl-CoA oxidase deficient mutants of Yarrowia lipolytica. Biotechnol Lett 27:859–864
Sowden RJ, Yasmin S, Rees NH, Bell SG, Wong L-L (2005) Biotransformation of the sesquiterpene (+)-valencene by cytochrome P450cam and P450BM-3. Org Biomol Chem 3:57–64
Tsotsou GE, Cass AEG, Gilardi G (2002) High throughput assay for cytochrome P450 BM3 for screening libraries of substrates and combinatorial mutants. Biosens Bioelectron 17:119–131
Wen LP, Fulco AJ (1987) Cloning of the gene encoding a catalytically self-sufficient cytochrome P-450 fatty acid monooxygenase induced by barbiturates in Bacillus megaterium and its functional expression and regulation in heterologous (Escherichia coli) and homologous (Bacillus megaterium) hosts. J Biol Chem 262:6676–6682
Whitehouse CJC, Bell SG, Tufton HG, Kenny RJP, Ogilvie LCI, Wong L-L (2008a) Evolved CYP102A1 (P450BM3) variants oxidise a range of non-natural substrates and offer new selectivity options. Chem Commun 8:966–968
Whitehouse CJC, Bell SG, Wong L-L (2008b) Desaturation of alkylbenzenes by cytochrome P450BM3 (CYP102A1). Chem Eur J 14:10905–10908
Whitehouse CJC, Bell SG, Yang W, Yorke JA, Blanford CF, Strong AJF, Morse EJ, Bartlam M, Rao Z, Wong LL (2009) A highly active single-mutation variant of P450BM3 (CYP102A1). Chembiochem 10:1654–1656
Wodnicka M, Guarino RD, Hemperly JJ, Timmins MR, Stitt D, Pitner JB (2000) Novel fluorescent technology platform for high throughput cytotoxicity and proliferation assays. Biomol Screen 5:141–152
Acknowledgments
Financial support by the University of the Free State, the South African National Research Foundation, and the South African Department of Science and Technology/National Research Foundation Centre of Excellence in Catalysis is gratefully acknowledged. We thank Prof. Vlada B. Urlacher for providing the pET28a-CYP102A1 plasmid, as well as Prof. J. Albertyn and Dr. K. Syed for assistance with transformation into E. coli. We also thank Sarel Marais for technical assistance and Charlene Randall for assisting in the preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
South African DST-NRF Centre of Excellence in Catalysis, c*change
Rights and permissions
About this article
Cite this article
Gudiminchi, R.K., Smit, M.S. Identification and characterization of 4-hexylbenzoic acid and 4-nonyloxybenzoic acid as substrates of CYP102A1. Appl Microbiol Biotechnol 90, 117–126 (2011). https://doi.org/10.1007/s00253-010-3029-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-010-3029-x